Kyverna Therapeutics, Inc. · NASDAQ:KYTX
BlackRock, Inc. reported a 5.10% stake in Kyverna Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Jul 29, 2026
BlackRock, Inc. reported a 5.10% stake in Kyverna Therapeutics, Inc., 3,103,757 shares, as a passive investor on Jun 30, 2026. Filed Jul 29, 2026 (Schedule 13G).
- Stake
- 5.10%
- Shares
- 3,103,757
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 5.10% | 3,103,757 |
Source
Related
- Kyverna Therapeutics, Inc.
- BlackRock, Inc.
- Kyverna Therapeutics, Inc. shareholders
- Schedule 13G · Orin Hirschman · Oct 19, 2026
- Schedule 13G/A · Bain Capital Life Sciences Opportunities III, LP · Aug 14, 2026
- Form 4 · Clark Ian T · May 29, 2026
- Form 4 · Cohen Fred E · May 29, 2026
- Form 4 · Seidenberg Beth C · May 29, 2026